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Wenxin Keli (WXKL) is a widely used Chinese botanical drug for the treatment of
arrhythmia, which is consisted of four herbs and amber. In the present study, we
analyzed the chemical composition of WXKL using liquid chromatography coupled with
high-resolution mass spectrometry (LC-HRMS) to tentatively identify 71 compounds.
Through typical separate procession, the total extract of WXKL was divided into fractions
for further bioassays. Cardiomyocytes and zebrafish larvae were applied for assessment.
In vivo arrhythmia model in Cmlc2-GFP transgenic zebrafish was induced by terfenadine,
which exhibited obvious reduction of heart rate and occurrence of atrioventricular block.
Dynamic beating of heart was recorded by fluorescent microscope and sensitive camera
to automatically recognize the rhythm of heartbeat in zebrafish larvae. By integrating
the chemical information of WXKL and corresponding bioactivities of these fractions,
activity index (AI) of each identified compound was calculated to screen potential active
compounds. The results showed that dozens of compounds including ginsenoside Rg1,
ginsenoside Re, notoginsenoside R1, lobetyolin, and lobetyolinin were contributed to
cardioprotective effects of WXKL. The anti-arrhythmic activities of five compounds were
further validated in larvae model and mature zebrafish by measuring electrocardiogram
(ECG). Our findings provide a successful example for rapid discovery of bioactive
compounds from traditional Chinese medicine (TCM) by activity index based approach
coupled with in vivo zebrafish model.
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INTRODUCTION
Natural products have played important roles in healthcare system throughout history and will
continue to be served as huge and invaluable resource for the discovery of drug candidates.
Traditional Chinese Medicine (TCM), widely used in Eastern Asian countries, has been regarded
as an important part of natural products for the therapy of various diseases (Wang et al., 2012).
The discovery of bioactive constituents from TCM is the key step in the modernization of TCM.
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As a consequence, developing high throughput methods with
satisfied sensitivity for identifying active compounds from
complex mixtures of TCM is in great demand. In past two
decades, many efforts have been made for rapidly screening
of compounds from TCM. Artemisinin (qinghaosu) with
antimalarial effect is a successful and impressive example as the
gift from TCM (Tu, 2011).
Arrhythmia occurs with abnormal beating of heart
myocardium, generally represent disorder of ion channels
or cardiomyopathy, can be classified with disorders of impulse
formation or conduction. Arrhythmia has intricate pathogenesis,
in general, most cardiovascular diseases such as heart failure
always accompany with arrhythmia. Some types of arrhythmias
are capable of triggering cardiac arrest and sudden death.
Unfortunately, most of the antiarrhythmic drugs lack specificity
and have numerous adverse effects (Page and Roden, 2005).
TCMs havemultitargets and synergy effect that benefit with those
complex diseases (Li et al., 2011). Wenxin Keli (WXKL) is one
of the widely used Chinese patent medicine for arrhythmia and
heart failure, and is the first Chinese-developed anti-arrhythmic
medicine approved by the China Food and Drug Administration
(CFDA) and approved by Chinese Pharmacopeia (ChP), and
consists of Codonopsis pilosula, Polygonatum sibiricum, Radix
Notoginseng, Nardostachys jatamansi, Succinum. Researches
in decades have proved that WXKL can suppress and prevent
cardiac arrhythmias, including atrial and ventricular arrhythmias
(Xing et al., 2013; He et al., 2016; Wang et al., 2016; Li et al.,
2017), and inhibit multiple ion channels (Chen et al., 2013;
Yang et al., 2017), especially the atrial-selective inhibition of
sodium-channel current (Burashnikov et al., 2012), and effect on
late Na current (Xue et al., 2013).
Arrhythmia is difficult to model in vitro, multiple elements
may contribute to the final arrhythmia including genetic
predisposition, extrinsic injury, environmental exposures, and
stochastic processes. Cell-based model unable to fully reveal the
pathological process of arrhythmia. On the other hand, using
animal model for screening is costly. Zebrafish (Danio rerio) has
been a model for biomedical research for decades and is ideal for
phenotype-based screen in various ways. The generation time of
adult fish is about 3 months and it is easy to maintain a great
number of zebrafish with low cost and needn’t much space. The
embryogenesis can be finished in 24 h post-fertilization (hpf)
and each pair of fish can produce more than hundred eggs and
the mating is not depended on season. More attractively, their
embryos are transparent and most organs including the heart,
liver, intestine, and kidney develop in 96 hpf that can be clearly
visualized (Barros et al., 2008). The larvae can be manipulated
in well-plate and live with a little fluid and is permeable to
small molecules (Zhang et al., 2003; Kari et al., 2007). These
traits make it possible to establish an easy and high-throughput
model to assay the effects of drug candidates on internal organs
in the live organism. Zebrafish are easy to genetic manipulation
to simulate human disease (Asnani and Peterson, 2014). As a
developmental and genetic model, zebrafish has been used for
anti-cancer compounds discovery, chemicals toxicity assessment,
and so on. Zebrafish heart is highly comparable with human
heart in structures, functions, signal pathways, and ion channels
(Hu et al., 2000) and is particularly suitable for the study of
the cardiovascular system. Here, we used terfenadine, an anti-
histamine drug but also a potent hERG blocker andQT prolonger
(Dhillon et al., 2013), and was reported that had pro-arrhythmic
effects (Chaudhari et al., 2013), to induce the heart disturbance of
zebrafish.
In the present study, we simultaneously used cell-based
and zebrafish-based model to assess the cardioprotective and
anti-arrhythmia effect of WXKL and the separated fractions,
and combined HRMS and chemometric analysis to identify
bioactive compounds from WXKL. H9c2 cell damaged by H2O2
were conducted to evaluate the protective activity of fractions.
In vivo arrhythmic model based on Cmlc2-GFP transgenic
(Tg) zebrafish was applied and the heart rate and rhythm
of larvae were measured to evaluate pharmacological effects.
The cell viability and heart rate recovery of zebrafish were
transformed as the bioactivity coefficient and correlated with
the compounds constitute in fractions from WXKL to calculate
active index of every compounds. The entire process is illustrated
in Figure 1. With both in vitro and in vivo assessment and active
index calculation, several compounds including ginsenoside Rg1,
ginsenoside Re, notoginsenoside R1, lobetyolin, lobetyolinin were
selected to validate the activity on larvae and mature fish.
MATERIALS AND METHODS
Materials and Reagents
Wenxin Keli was obtained from Shanxi Buchang Pharmaceutical
Co., Ltd (Shanxi, China). Ginsenoside Rg1, Ginsenoside Re,
Notoginsenoside R1 were purchased from Winherb Medical
Tech. Co., Ltd (Shanghai, China). Lobetyolin was obtained
from Push Bio-Tech (Chengdu, China). Extract of codonopsis
glycosides was obtained from Dasfbio (Nanjing, China).
HPLC-grade acetonitrile and methanol were purchased from
Merck (Darmstadt, Germany). Formic acid (HPLC grade) was
purchased from Roe Scientific (Newark, DE, USA). Ethanol
was purchased from Zhejiang Changqing Chemical (Hangzhou,
China). Deionized water was prepared with an Elga PURELAB
flex system (ELGA LabWater, UK).
High-glucose Dulbecco’s modified Eagle’s medium, fetal
bovine serum, trypsin-EDTA and antibiotics (100 U/ml penicillin
G and 100 g/mL streptomycin) were obtained from Gibico BRL
(Grand Island, NY, USA). Tert-Butyl hydroperoxide solution,
Thiazolyl Blue Tereazolium Bromide, Terfenadine, DMSO, N-
Phenylthiourea (PTU), and Tricaine were acquired from Sigma–
Aldrich (St. Louis, MO, USA).
Apparatus
Tecan infinite M1000 system (Tecan, Zurich, Switzerland). AB
TripleTOF 5600plus System (AB SCIEX, Framingham, USA),
coupled to a Waters ACQUITY UPLCTM system (Waters, MA,
USA). Finnigan LCQ DecaXPplus mass spectrometer equipped
with an ESI source (Thermo, MA, USA) coupled to Agilent 1100
liquid chromatography (Agilent, Waldbronn, Germany). Agilent
1200 preparative performance liquid chromatography (Agilent,
Waldbronn, Germany). Leica DMI 3000B Fluorescence Inversion
Microscope System (Leica Microsystems Inc., USA), Andor Zyla
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FIGURE 1 | Scheme of active index calculation based active compounds screening from WXKL.
5.5 sCMOS Cameras (Oxford Instruments plc, Tubney Woods,
Abingdon, UK). IX-100F Zebrafish system (iWorx Systems, Inc.,
USA).
Characterization of Major Compounds of
WXKL by LC–HRMS
Chemical composition of WXKL was characterized by AB
TripleTOF 5600plus System coupled to a Waters Acquity
UPLC system. The MS conditions: scan range m/z 100–2,000.
Negative ion mode: source voltage was−4.5 kV, and the source
temperature was 550◦C. Positive ion mode: source voltage was
+5.5 kV, and the source temperature was 600◦C. The pressure
of Gas 1 (Air) and Gas 2 (Air) were set to 50 psi. The
pressure of Curtain Gas (N2) was set to 35 psi. Maximum
allowed error was set to ±5 ppm. Declustering potential (DP),
100V; collision energy (CE), 10V. For MS/MS acquisition
mode, the parameters were almost the same except that the
collision energy (CE) was set at 50 ± 20V, ion release delay
(IRD) at 67, ion release width (IRW) at 25. The acquisition
parameters for Finnigan LCQ DecaXPplus mass spectrometer
were as follows: nebulizing gas, high purity nitrogen (N2);
collusion gas, high-purity helium (He); ion spray voltage:−3
kV; capillary temperature: 350◦C; capillary voltage:−15V; mass
range: m/z 100–1,500. Chromatographic separation was carried
out on an Agilent Zorbax SB-C18 analytical column (4.6 ×
250mm I.D., 5µm; Agilent Technologies, USA). The mobile
phase consisted of water (A) and acetonitrile (B) both containing
0.05% v/v formic acid. A gradient program was used as follows:
0–5min, 10% B; 5–15min, 10–25% B; 15–35min, 25–35% B; 35–
40min, 35–40% B; 40–45min, 40–70% B; 45–55min, 70–95% B;
55–65 min: 95% B. The flow rate was 0.5 mL/min, the column
temperature was 30◦C, and the injection volume was 20 µL.
Cell Culture and Anti-Oxidation Assays
H9c2 cell were obtained from Cell Bank of the Chinese Academy
of Science (Shanghai, China) and cultured in high glucose
Dulbecco’s modified Eagle’s medium supplemented containing
10% fetal bovine serum (FBS) and antibiotics (100 units/mL
penicillin and 100µg/mL streptomycin). The cultures were
maintained at 37◦C in a humidified atmosphere of 5% CO2.
The anti-oxidation activity of each fraction was determined by
tetrazolium based colorimetric assay (MTT assay). Briefly, cells
(5× 104 cell/mL) were seeded to 96-well plates for 24 h and then
treated with fractions of WXKL for another 24 h prior to 150µM
H2O2 exposure in fresh medium for 3 h, After that, 100 µL 0.5
mg/mL MTT in fresh medium replaced the former medium for
4 h at 37◦C. Then, the medium was replaced by 100 µL DMSO
and vibrated for 10min. The cell viabilities of tested fractions
were determined by measuring the optimal densities (ODs) of
untreated cells (control), the cells exposed to H2O2 (model), and
the cells pre-incubated with components (tested). The activities
of the components were calculated using the following formula:
Survival rate% = OD of tested/OD of control. Protection rate%
= (OD of model – OD of tested)/(OD of model – OD of control).
Zebrafish Husbandry and Management
Heterozygotes and homozygote transgenic Cmlc2-GFP zebrafish
expressing green fluorescent protein (GFP) exclusively in
myocardium were provided by Zebrafish Resource Center,
Zhejiang University School of Medicine (Hangzhou, China)
and maintained according to established standard procedures.
Two parent zebrafish were placed separately in a mating box
equipped with a separator to protect the eggs from being eaten.
Spawning was induced in the morning and embryos from
each box were collected and rinsed with system fish water
(containing 0.3% Instant Ocean Salt in deionized water with
final pH 6.9–7.2, conductivity 450–550 µs/cm, and hardness
of about 90 mg/L NaHCO3). The embryos were maintained
in the Petri dish with system fish water and transferred to
the incubator and incubated at 28◦C. This study was granted
by the Institutional Animal Care and Use Committee of the
Laboratory Animal Center, Zhejiang University. We followed
the relevant guidelines from the Laboratory Animal Center of
Zhejiang University.
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Zebrafish Arrhythmia Model and Drug
Incubation
In 24 hpf, larvae with fluorescence were picked under fluorescent
microscope and membranes of these larvae were ruptured
artificially. Larvae were distributed into a 24-well plate and
8–10 larvae in each well with system fish water added
with 0.2mM N-Phenylthiourea (PTU) and 6 nM methylene
blue for treatment. Set groups by wells, including Control,
Model, and Treat. Terfenadine was stocked in DMSO at
100mM, fractions of WXKL was stocked in DMSO at 100
mg/mL and fish water was used to dilute the stock to
appropriate concentration. The model group was only given
terfenadine, and the treat groups were given terfenadine and
corresponding fractions. In 48 hpf incubating, the previous
medium was discarded, and added fractions and terfenadine
working solution, according to the groups, and filled to 2mL
with fish water medium in each well. The final concentrations
of terfenadine was 6µM. The fractions were diluted to
appropriate concentration, mostly 50µg/mL and some were
25, 12.5, 6.25µg/mL, depending on the toxicity refer to cell
assay.
Heartbeat Recording
In 72 hpf, the beating of zebrafish heart was recorded under
florescence with Leica DMI 3000B Fluorescence Inversion
Microscope System (Leica). The readout speed of the sCMOS
camera was set at 10 frames or 20 frames per second
with 4 × 4 pixel binning. L5 filter cube (excitation wave
length of 480 nm and emission wave length of 527 nm).
One hundred continuous dynamic images were captured
by Zyla 5.5 sCMOS Cameras (Andor), subsequently were
recognized by Matlab. The area of heart in each picture
was measured. The area change with time was supposed to
exhibit the heart rhythm. The heartbeats were also recorded
manually for accuracy. We calculated the heartbeat of ventricle
uniformly.
Calculation of the Activity Indexes
The recovery rate (Ri) of the components were calculated using
the following formula:
Ri =
Bi − BM
BC − BM
× 100%
Ri: normalized heart rate recovery rate of fraction i; Bi: beats
of larvae treated by fraction i; BM : beats of larvae treated by
terfenadine; BC: beats of larvae treated in control group.
The peak area of each compound was normalized according
to the following formula:
Aj =
Ai,j∑m
i=1 Ai,j
Aj: normalized values of peak area of constituent j in fraction i;
Ai,j: peak area of compound j in fraction i; m: the numbers of
fractions obtained from whole extract.
The activity indexes of compounds were given by the
following formula:
AIj =
∑
(Ri×Aj)
AIj: activity index of compound j.
Zebrafish ECG Measurement
The ECG of zebrafish was measured by IX-100F Zebrafish system
(iWorx Systems, Inc., USA). Zebrafish was anesthetic at first and
positioned on its back on a fish-bed. Use a paper to gently remove
excess water and ensure that the fins are not crossing the belly
of the fish. Place the fish-bed with the fish, head to the right, in
the chamber and position it under Ag/AgCl surface electrodes.
The two electrodes were placed axially along the center-line of
the fish’s belly and the forward electrode should be placed close
to the gills. ECG was recorded by LabScribe v3 software (iWorx
System Inc., USA).
Statistical Analysis
The data are expressed as mean ± standard deviation (SD).
Parameter comparisons between groups were made with one-
way ANOVA analysis of variance. GraphPad prism 7 software
(GraphPad Software, USA) was used to carry out statistical
analysis. P < 0.05 was considered statistically significant.
RESULTS AND DISCUSSION
The Chemical Composition of Wenxin Keli
Extract
The main compounds of WXKL include sugar, glycosides,
lignans, polyynes, saponins, iridoid glycosides, detailed
information is listed in Table 1. The negative ion model
base peak LC-MS chromatograms of WXKL was showed as
Figure 2. We collected 71 compounds information of MS/MS
and identified 53 compounds primarily, including saponins,
phenylpropanoids, polyacetylene, triterpenoid, and others.
Twenty-seven compounds of them belong to Notoginseng,
including notoginsenoside R1, ginsenoside Rg1, ginsenoside
Re, ginsenoside Ra3, ginsenoside Rb1, notoginsenoside R2,
ginsenoside Rc, ginsenoside Rd and so on. Sixteen compounds
belong to Codonopsis, including tangshenoside V, lobetyolinin,
lobetyolin, atractylenolide III, gentisic acid β-D-glucoside,
syringin, hexyl 6-O-β-D-glucopyranosyl-β-D-glucopyranoside,
hexyl 2-O-β-D-glucopyranosyl-beta-D-glucopyranoside and
others. Besides, 5 were identified from Polygonatum, and 2 were
from Nard (Table 1).
Evaluating Cardioprotective Effect of
Components by Zebrafish Arrhythmia
Model
We first performed standard isolation by preparative
chromatography to obtain fractions, which were analyzed
by Finnigan LCQ DecaXPplus mass spectrometer. The
mass spectrums of every fractions were shown in
Supplementary Material.
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TABLE 1 | Chromatographic and mass spectral data of the constituents of WXKL.
Peak
No.
tR (min) Identification Detected
(m/z)
Molecular
formula
Error
(ppm)
MS/MS
(m/z)
Source
1 4.427 Raffinose 503.1598 C18H32O16 −3.9 383.1174
221.0651
179.0548
2 4.58 Sucrose or lactose 341.1089 C12H22O11 −1.9 179.0555 [M-H-C6H10O5]
−
161.0459 [M-H-C6H12O6]
−
119.0349 [M-H-C6H10O5-2CH2O]
−
101.0247 [M-H-C6H10O5-2CH2O-H2O]
−
3 6.533 Difructose anhydride III 323.0976 C12H20O10 −2.4 99.0459
4 8.104 Unknown 326.124 C15H21NO7 −1.6 164.0708 [M-H-Glc]
−
5 9.508 Vanillic acid
4-O-neohesperidoside
475.1446 C20H28O13 −2.3 167.0345 [M-H-Glc-Rha]
− HJ
152.011 [M-H-2C6H11O5]
−
108.0218 [M-H-2C6H11O5-CO2]
−
6 10.07 Gentisic acid β-D-glucoside 315.0718 C13H16O9 −1.1 153.0182 [M-H-Glc]
− DS
152.0110 [M-H-Glc-H]−
109.0289 [M-H-Glc-CO2]
−
108.0217 [M-H-Glc-H-CO2]
−
7 10.35 Unknown 375.1287 C16H24O10 −2.6 213.0757 [M-H-Glc]
−
169.0860 [M-H-Glc-CO2]
−
151.0752 [M-H-Glc-CO2-H2O]
−
125.0607 [M-H-Glc-C3H4O3]
−
8 13.103 Neochlorogenic acid 353.0876 C16H18O9 −0.6 191.0560 [M-H-C9H6O3]
− DS
179.0344 [M-H-C7H10O5]
−
173.0456 [M-H-C9H8O4]
−
135.0453 [M-H-C8H10O7]
−
107.0503 [M-H-C10H14O7]
−
9 14.29 Syringin 371.1339 C17H24O9 −2.3 417.1396 [M-H+FA]
− DS
10 15.697 Codonopilate A 718.2728 C49H82O3 None 598.2277 DS
Or Codonopilate B 335.1248
303.1002
11 15.917 Chlorogenic acid 353.0877 C16H18O9 −0.3 191.0557 [M-H-C9H6O3]
− DS
179.0352 [M-H-C7H10O5]
−
173.0449 [M-H-C9H8O4]
−
135.0446 [M-H-C8H10O7]
−
12 16.263 Cryptochlorogenic acid 353.0873 C16H18O9 −1.4 191.0560 [M-H-C9H6O3]
− DS
179.0344 [M-H-C7H10O5]
−
173.0456 [M-H-C9H8O4]
−
135.0453 [M-H-C8H10O7]
−
107.0503 [M-H-C10H14O7]
−
13 17.038 Unknown 779.2739 C37H48O18 −3.7 437.1571 [M-H-Glc-C6H12O6]
− HJ
14 17.529 Vina-ginsenoside R15 815.2829 C33H52O23 0.3 861.3002 [M-H+FA]
− SQ
653.4300 [M-H-Glc]−
491.3754 [M-H-2Glc]−
15 17.562 Unknown 617.2197 C31H38O13 −6.9 663.2250 [M-H+FA]
−
437.1574 [M-H- C6H12O6]
−
365.1357
293.1143
16 17.874 Unknown 455.1662 C32H24O3 2 293.1151 [M-H-Glc]
−
(Continued)
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TABLE 1 | Continued
Peak
No.
tR (min) Identification Detected
(m/z)
Molecular
formula
Error
(ppm)
MS/MS
(m/z)
Source
17 19.878 Hexyl 6-O-β-D-glucopyranosyl-
β-D-glucopyranoside
425.2017 C18H34O11 −2.7 471.2076 [M-H+FA]
− DS
179.0560 [M-H-C12H22O5]
−
143.0327 [M-H-C6H14O-C6H12O6]
−
101.0243 [M-H-C12H20O10]
−
18 20.04 Deoxyloganic Acid 359.1342 C16H24O9 −1.5 197.081 [M-H-Glc]
− DS or HJ
153.0917 [M-H-Glc-CO2]
−
135.0811 [M-H-Glc-CO2-H2O]
−
19 20.132 Hexyl 2-O-β-D-glucopyranosyl-
β-D-glucopyranoside
425.2017 C18H34O11 −2.7 263.1492 [M-H-C6H10O5]
−
179.0560 [M-H-C12H22O5]
−
143.0327 [M-H-C6H14O-C6H12O6]
−
101.0243 [M-H-C12H20O10]
−
20 20.678 Tangshenoside V 469.1348 C21H26O12 −0.7 325.0923 [M-H-C6H8O4]
− DS
265.0717 [M-H-C8H12O6]
−
235.0608 [M-H-C9H14O7]
−
205.05 [M-H-C10H16O8]
−
163.0396 [M-H-C12H18O9]
−
145.0289 [M-H-C12H18O9-H2O]
−
99.0465 [M-H-C15H18O8-CO2]
−
21 21.697 Unknown 313.1649 C16H26O6 −2.4 359.1688 [M-H+FA]
−
22 22.033 Lobetyolinin 557.2232 C26H38O13 −1.4 603.2292 [M-H+FA]- DS
323.0984 [M-H-C14H18O3]
−
233.1166 [M-H-C12H20O10]
−
221.0661 [M-H-C18H24O6]
−
179.0554 [M-H-C20H26O7]
−
161.045 [M-H-C20H28O8]
−
119.0347 [M-H-C18H30O12]
−
23 22.621 20-(β-D-glucopyranosyloxy)-
ginsenoside Rf or
Vina-ginsenoside R4
961.5399 C48H82O19 2.2 1007.5456 [M-H+FA]
− SQ
799.493[M-H-Glc]−
637.4365[M-H-2Glc]−
24 23.362 Notoginsenoside R1 931.5281 C47H80O18 1 977.534 [M-H+FA]
− SQ
799.4936 [M-H-Xyl]−
769.4832 [M-H-Glc]−
637.4373 [M-H-Xyl-Glc]−
475.3832 [M-H-Xyl-2Glc]−
25 24.286 Isoheptanol
2(S)-O-β-D-xylopyranosyl-(1→
6)-O-β-D-glucopyranoside
409.2071 C18H34O10 −2 276.0881 [M-H-133]
− HJ
Or isoheptanol
2(S)-O-β-D-apiofuranosyl-(1→
6)-O-β-D-glucopyranoside
217.0494 [M-H-192]−
Or n-hexanol O-rutinoside
26 24.923 Ginsenoside Re 945.5443 C48H82O18 1.5 991.5504 [M-H+FA]
− SQ
783.4995 [M-H-Glc]−
637.4377 [M-H-Glc-Rha]−
27 25.073 Ginsenoside Rg1 799.4859 C42H72O14 1.2 845.4913 [M-H+FA]
− SQ
637.4392 [M-H-Glc]−
475.3822 [M-H-2Glc]−
391.2879 [M-H-2Glc-C6H12]
−
(Continued)
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TABLE 1 | Continued
Peak
No.
tR (min) Identification Detected
(m/z)
Molecular
formula
Error
(ppm)
MS/MS
(m/z)
Source
28 25.963 Lobetyolin 395.1705 C20H28O8 −1.6 441.1765 [M-H+FA]
− DS
233.1180 [M-H-Glc]−
215.1060 [M-H-Glc-H2O]
−
185.0968 [M-H-Glc-H2O-CH2O]
−
159.0813 [M-H-Glc-H2O-C3H4O]
−
143.0711 [M-H-Glc-C7H6]
−
125.0603 [M-H-Glc-C7H6-H2O]
−
29 27.235 2,2,6-trimethylcyclohexanone 187.0982 C9H16O4 3.3 GS
30 28.512 Unknown 445.0772 C21H18O11 −1 269.0448 [M-H-C6H8O6]
− DS or HJ
31 28.796 Notoginsenoside G 959.5233 C48H80O19 1.2 1005.5306 [M-H+FA]
− SQ
32 30.678 14-hydroxy-lactarolide A 297.1338 C15H22O6 −1.9 343.1383 [M-H+FA]
−
235.1724 [M-H-62]−
191.1431 [M-H-106(62+46)]−
33 31.183 Vina-ginsenoside R2 827.4801 C43H72O15 0.3 781.4769 [M-H-HCOOH]
− SQ
34 33.446 Madecassic acid 503.3373 C30H48O6 −1 459.3116 [M-H-CO2]
−
Or terminolic acid
35 33.772 Unknown 419.1448 C32H20O 1.6
36 34.161 Unknown 401.135 C32H18 3.6
37 35.266 Notoginsenoside Fa 1239.6392 C59H100O27 1 1285.645 [M-H+FA]
− SQ
1107.603 [M-H- C5H8O4]
−
945.551 [M-H- C5H8O4-Glc]
−
783.4893 [M-H- C5H8O4-2Glc]
−
621.4405 [M-H- C5H8O4-3Glc]
−
38 35.949 Unknown 276.0879 C14H15NO5 0.6
39 36.816 Ginsenoside Ra3 1239.6398 C59H100O27 1.5 1285.6455 [M-H+FA]
− SQ
1107.603 [M-H- C5H8O4]
−
945.551 [M-H- C5H8O4-Glc]
−
783.4893 [M-H- C5H8O4-2Glc]
−
621.4405 [M-H- C5H8O4-3Glc]
−
40 37.686 Chikusetsusaponin L5 901.517 C46H78O17 0.4 947.5234 [M-H+FA]
− SQ
Or Chikusetsusaponin LM2 769.4828 [M-H-132]
−
41 38.845 Notoginsenoside R4 1239.6381 C59H100O27 0.1 1285.645 [M-H+FA]
− SQ
1107.603 [M-H- C5H8O4]
−
945.551 [M-H- C5H8O4Glc]
−
783.4893 [M-H- C5H8O4-2Glc]
−
621.4405 [M-H- C5H8O4-3Glc]
−
42 39.161 Ginsenoside Rb1 1107.5963 C54H92O23 0.6 1153.6012 [M-H+FA]
− SQ
1061.5274 [M-H-46]−
945.554 [M-H-Glc]−
43 39.855 Notoginsenoside R2 769.4742 C41H70O13 −0.2 815.4801 [M-H+FA]
− SQ
637.4367 [M-H-Xyl]−
619.4250 [M-H-Xyl-H2O]
−
475.3813 [M-H-Xyl-Glc]−
391.2869 [M-H-Xyl-Glc-C6H12]
−
44 39.923 Polygonatoside D or isomer 899.465 C45H72O18 0.5 753.2310 [M-H-Rha]
− HJ
737.4188 [M-H-Glc]−
429.2190 [M-H-2Glc-Rha]−
(Continued)
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TABLE 1 | Continued
Peak
No.
tR (min) Identification Detected
(m/z)
Molecular
formula
Error
(ppm)
MS/MS
(m/z)
Source
45 41.725 S-ginsenoside Rg2 783.4894 C42H72O13 −0.8 829.4958 [M-H+FA]
− SQ
637.4348 [M-H-Rha]−
475.3809 [M-H-Rha-Glc]−
46 42.073 Ginsenoside Rc 1077.585 C53H90O22 −0.1 1123.5909 [M-H+FA]
− SQ
945.5531 [M-H- C5H8O4]
−
783.4964 [M-H- C5H8O4-Glc]
−
621.4409 [M-H- C5H8O4-2Glc]
−
459.3871 [M-H- C5H8O4-3Glc]
−
47 42.147 R-ginsenoside Rg2 783.4896 C42H72O13 −0.5 SQ
48 42.422 Ginsenoside Rb2 1077.585 C53H90O22 −0.1 1123.5909 [M-H+FA]
− SQ
49 42.533 (20R)-Ginsenoside Rh1 637.4309 C36H62O9 −1.9 683.4371 [M-H+FA]
− SQ
475.3793 [M-H-Glc]−
50 43.06 Ginsenoside Rb3 1077.585 C53H90O22 −0.1 1123.5909 [M-H+FA]
− SQ
51 43.469 Ginsenoside Rh1 637.4308 C36H62O9 −2.1 683.4374 [M-H+FA]
− SQ
475.3793 [M-H-Glc]−
52 43.835 Unknown 489.3205 C29H46O6 −3.4 535.3265 [M-H+FA]
−
53 44.41 5,6,9-trihydroxy-octadec-7-
enoic acid
329.2332 C18H34O5 −0.4 229.1443 DS
211.1338
54 44.788 Ginsenoside Rd 945.5423 C48H82O18 −0.6 991.5476 [M-H+FA]
− SQ
783.4963 [M-H-Glc]−
621.4396 [M-H-2Glc]−
55 45.359 Ginsenoside F1 637.4308 C36H62O9 −2.1 683.4374 [M-H+FA]
− SQ
475.3793 [M-H-Glc]−
56 46.429 Unknown 677.2456 C33H42O15 0.7
57 46.468 Unknown 501.3214 C30H46O6 −1.5 547.3264 [M-H+FA]
−
58 47.455 Notoginsenside T5 751.4631 C41H68O12 −0.9 797.4692 [M-H+FA]
− DS
619.4254 [M-H- C5H8O4]
−
59 47.995 Aractylenolide III 247.1343 C15H20O3 1.3 DS
60 48.41 Unknown 487.3042 C29H44O6 −4.7 533.3104 [M-H+FA]
−
441.3025 [M-H-46]−
61 48.933 20(S)-Ginsenoside Rg3 783.4897 C42H72O13 −0.4 829.4962 [M-H+FA]
− SQ
621.4415 [M-H-Glc]−
459.3859 [M-H-2Glc]−
62 48.975 Ginsenoside Rh4 619.4192 C36H60O8 −3.8 665.4272 [M-H+FA]
− SQ
Or Ginsenoside Rk3
63 49.098 20(R)-Ginsenoside Rg3 783.4895 C42H72O13 −0.7 829.4962 [M-H+FA]
− SQ
621.4415 [M-H-Glc]−
459.3856 [M-H-2Glc]−
64 49.71 3-(4
′
-hydroxy-benzyl)-5,7-
dihydroxy-6,8-dimethyl-
chroman-4-one
313.1078 C18H18O5 −1.1 207.0649 [M-H-C7H6O]
− HJ
205.0502 [M-H-C7H8O]
−
179.0700 [M-H-C9H10O]
−
165.0549 [M-H-C9H8O2]
−
65 50.172 Unknown 485.326 C30H46O5 −2.6 531.3322 [M-H+FA]
−
441.3002 [M-H-CO2]
−
66 50.573 Lobetyol 247.1342 C14H18O 0.9 247.1342 [M-H+FA]
− DS
67 50.819 Nardosinone 249.1497 C15H22O3 0.3 295.1550 [M-H+FA]
− GS
68 52.662 Unknown 457.2949 C28H42O5 −2.3 295.2452 [M-H-Glc]
−
(Continued)
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TABLE 1 | Continued
Peak
No.
tR (min) Identification Detected
(m/z)
Molecular
formula
Error
(ppm)
MS/MS
(m/z)
Source
69 52.921 Ginsenoside Rk1 765.4785 C42H70O12 −1.2 811.4851 [M-H+FA]
− SQ
Or Ginsenoside Rg5 603.4289 [M-H-Glc]
−
279.1597 [M-H-3Glc]−
70 53.449 Unknown 455.2793 C28H40O5 −2.2 501.2858 [M-H+FA]
−
411.2912 [M-H-CO2]
−
71 55.169 Unknown 499.3056 C30H44O6 −1.8 545.3107 [M-H+FA]
−
455.3182 [M-H-CO2]
−
411.3280 [M-H-2CO2]
−
DS, Codonopsis pilosula; HJ, Polygonatum sibiricum; SQ, Radix Notoginseng, GS, Nardostachys jatamansi.
FIGURE 2 | Negative ion model HPLC–MS base peak chromatograms of WXKL.
Oxidative stress plays a key role in the pathogenesis of
various diseases (Furukawa et al., 2004). These fractions were
then evaluated the protective activity on H9c2 cell damaged
by H2O2. The toxicity of all fractions were tested at first,
and the safe concentration of most fraction were 50µg/mL,
and some were 25/12.5/6.25µg/mL to insure no toxicity.
The cell viability with these fractions treated were shown in
Supplementary Material.
Zebrafish (D. rerio) has been an ideal model for drug
screening (Goldsmith, 2004). There have been many applications
of zebrafish as a high-throughput screening model and
cardiotoxicity risk assessment of drug candidates (Wen et al.,
2012; Zhu et al., 2014). Here we used Cmlc2-GFP Tg zebrafish
as the base. This transgenic line expressing GFP exclusively in
myocardium driven by promoter cmlc2 (cardiac myosin light
chain 2 gene) (Huang et al., 2003). Terfenadine has been reported
can induce QT prolongation in zebrafish and guinea pig (Milan
et al., 2006; Lu et al., 2012; Chaudhari et al., 2013), which is
associated with ventricular tachyarrhythmia (Gowda et al., 2004).
Terfenadine causes QT prolongation in adult zebrafish, also
demonstrate in zebrafish embryos (Langheinrich et al., 2003).
As shown in Figure 3, terfenadine had less effect on
the structure of the heart (Figure 3A) but influenced the
rhythm of beat obviously (Figure 3B). The rhythm of heartbeat
was exhibited through the area change of heart analyzed
by Matlab. It’s obvious that the control groups performed
fast and regular rhythm (about 180 beats/min), and in the
model groups, the heart rate were down to 80–100 beats/min
with irregular heartbeats after incubated with terfenadine for
24 h, and some showed typically atrioventricular block (Peal
et al., 2011), while co-incubated with WXKL stabilized the
rhythm (Figure 3B, Supplementary Videos). AndWXKL and its
fractions performed varying affection on heart rate. Fraction 1
and Fraction 2 and former part of Fraction 3 showed beneficial
effect on heart rate, while the remaining parts of Fraction 3
lowered the rate even more (Figure 3C).
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FIGURE 3 | Cardioprotection of Wenxin Keli and fractions on zebrafish model. (A) Represent images of heart structures in zebrafish under bright-field and
fluorescence. (B) Represent images of heartbeat rhythm of different groups exhibited by Matlab. (C) Normalized heart rate of zebrafish larvae influenced by WXKL
fractions. n ≥ 8. ##P < 0.01 vs. control, *P < 0.05, **P < 0.01 vs. model.
Screening Active Compounds by Activity
Indexes Calculation and Ranking
Activity index (AI) of each compound was calculated according
to mathematical formulae proposed in our previous study. It
was assumed that the compounds with positive activity index
might be active and has contribution to the activity of whole
formula to some extent (Wang et al., 2014). The relative
intensities of the identified compounds in each fraction were
visually presented in a heatmap (Figure 4A). After multiply
corresponding bioactivity coefficient (i.e., heart rate recovery
rate) of each fraction, the heatmapwas converted into a bio-active
map, and the red and gray color represent good or bad effect,
respectively. The calculated scores were exhibited as histogram
on the right (Figure 4B). The detailed scores were listed in
Supplementary Material. We plot compounds with the effect on
cardiomyocytes and the heart rate of zebrafish (Figure 4C), the
compounds in upper right region represented a better activity.
Validation of Active Compounds
According to the scores, Ginsenoside Rg1, Ginsenoside Re,
Notoginsenoside R1, Lobetyolin, Lobetyolinin were selected to
validate activity, considering the available. Lobetyolinin was
prepared and enriched by ourselves from commercial codonopsis
glycosides. Their toxicity was confirmed before.We increased the
dosage of terfenadine and shortened the incubation time as an
acute injury model to improve significance when validating the
active of pure compounds by reason of the pure compounds were
not strong enough to exhibit activity in original method. After
pre-treated with compounds (50µM) for 24 h, the larvae were
treated with 15µM terfenadine for 2 h and recorded heartbeat
under fluorescent. As the consequence, the heart rate of larvae
was recovered in varying degree (Figure 5A). Ginsenoside Rg1
and lobetyolinin exhibited better activities. Meanwhile, ECG
of adult zebrafish treated with compound was measured. The
heart rate of normal zebrafish was around 100 beats/min, and
after treated with 25µM terfenadine for 1 h, the heart rate was
down and occurred irregular rhythm (Figure 5B). Lobetyolinin
pre-treated for 6 h recovered the heart rate and represent
electrocardiograms were showed as Figure 5C.
DISCUSSION
A few researches described the chemical components of WXKL.
Wang et al. established a database for the chemical components of
the five herbs inWXKL for active compounds predication (Wang
et al., 2017), however, all the compounds were acquired from
database refer to the herb not the real composition of the patent
drug, and the chemical components probably change during
the manufactory process. We analyzed the extract of WXKL
directly with LC-HRMS at beginning, but the analytic method
we established still has limitation. Actually, the compounds
in Fraction 2 weren’t separated clearly and seemed have low
mass spectrum response, which make this portion of fractions
have similar composition. Compounds identified from Nard
and Succinum were rare, maybe for the reason that the main
constitutes ofNard and Succinum are volatile oil, which are more
appropriate analyzed by gas chromatography–mass spectrometry
(GC–MS). According to report, the extracts of Nard significantly
blocked INa and IIto of rat ventricular myocytes (Liu et al.,
2009). The active compounds we predicted especially on the top
are minor composition were difficult to get standard substance
for bioactive assays except ginsenoside Re, ginsenoside Rg1
and notoginsenoside R1, which limited the further validation.
We attempted to isolate substances such as lobetyolinin from
extracts of C. pilosula. It has reported that ginsenoside Re has
negative effect on cardiac contractility and autorhythmicity (Peng
et al., 2012), ginsenoside Rg1 prolonged ventricular refractoriness
and repolarization (Wu et al., 1995), notoginsenoside R1 has
protective effects on cardiovascular system (Li et al., 2014).
Related activity of lobetyolin has few reports.
Drug-induced model is a common approach, verapamil and
terfenadine were applied to develop a zebrafish heart failure
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FIGURE 4 | Identification of active compounds by coefficient ranking. (A) Heatmap for relative content of identified compounds in each WXKL fractions. (B) Bio-active
map was converted from content map and corresponding bioactivity coefficient in each fraction, and active indexes of identified compounds were calculated and
showed on the right. (C) Compounds were plot by cell protection and bio-active scores and mass spectrum of several compounds on top. X axis means the
contribution of compounds to the cardiomyocytes protection. Y axis means the AI of compounds.
model (Zhu et al., 2018). QT prolonging is a typical characteristic
of arrhythmia which also can be induced by cisapride and
astemizole besides terfenadine (Langheinrich et al., 2003). It
has to be considered that drug treated by oral may cause
unstable effect, so design rational approaches of drug treatment is
necessary. Chaudhari et al. performed parenteral administration
of terfenadine with different doses and recorded ECG to
assess drug-induced QTc prolongation in zebrafish. Those with
the doses above 1 mg/kg were observed some proarrhythmic
effects such as Ventricular Premature Contractions, Ventricular
Tachycardia, Atrio-Ventricular (AV) Block, and Torsade de
pointes (TdP) (Chaudhari et al., 2013). However, the cardiotoxic
of terfenadine is possible not associated with QT prolongation
and the occurrence of TdPs, but with marked widening of the
QRS complex and other cardiac arrhythmias (Hondeghem et al.,
2011). It’s reported that terfenadine caused non-TdP like VT/VF
by slowing of conduction via blockade of INa (Lu et al., 2012).
In addition, transgenic zebrafish lines are also feasible to avoid
the unstable results of drug induce method. Several mutants were
identified that exhibited arrhythmias (Milan and Macrae, 2008)
like the bradycardic line slo mo, with variable degrees of sinoatrial
or atrioventricular heart block (Baker et al., 1997). Besides,
some mutants exhibited recessive lethal phenotypes included
mutants such as tremblor (Langenbacher et al., 2005), island beat
(Rottbauer et al., 2001), and reggae (Hassel et al., 2008). The
Tg line that express fluorescent proteins (e.g., Cmlc2-GFP) was
beneficial for optical measurement from the other perspective.
ECG (electrocardiogram) abnormalities is the critical
characteristic of arrhythmia. Several ECG measurement
equipments for zebrafish have been developed, and mostly
of them consist of electrode or micropipette and electrical
filter (Milan et al., 2006; Chaudhari et al., 2013; Dhillon et al.,
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FIGURE 5 | (A) Normalized heart rate of zebrafish larvae treated with compounds. n = 7. #P < 0.05 vs. control, ##P < 0.01 vs. control, *P < 0.05, **P < 0.01 vs.
model. (B) The schematic of ECG measurement, and the result of different group. n = 3. (C) Represent electrocardiograms of adult zebrafish treated in different
groups.
2013). Detection of 3 dpf larva is also possible (Chi et al.,
2008). However, the invasive injury and anesthesia could cause
damage to the individual. As for high throughput screening,
a fast and stable method of ECG measurement is required,
but existing devices seem not compatibility. Computerized
recognition of ECGs has become a well-established practice,
assisting to classify long-term ECG recordings, which suggests
new approaches like Machine Learning are able to recognize and
classify the rhythm signal. For instance, automatic classification
of single-lead ECG signals with Deep learning (also known
as unsupervised feature learning or representation learning)
was established (Singh et al., 2018). A new semi-supervised
approach based on deep learning and active learning for
classification of electrocardiogram signals is proposed (Sayantan
et al., 2018). Though several algorithms have focused on
automatically classifying heartbeats in ECGs, the scalability
failure to handle large intra-class variations wherein the
robustness of many existing ECG classification techniques
remains limited. We have acquired plenty of dynamic images
of different conditions of heartbeat and attempt to establish
the relationship between waveform and define characteristic
to classify the phenotype. Rhythm classify method based on
image processing will be a non-invasive measurement of heart
regulation.
In conclusion, we identified 71 compounds from extract
of WXKL by LC-HRMS, and firstly utilized a transgenic
zebrafish cmlc2-GFP induced by terfenadine as an animal
model for screening active compounds from WXKL. After
recording heartbeat that affected by fractions under a fluorescent
microscope, a convenient image process was applied to
exhibit the rhythm of heartbeat. Subsequently, we integrated
chemometric analysis with bio-activity in vivo model of
corresponding fractions and calculated active index of identified
compounds. Ginsenoside Rg1, ginsenoside Re, notoginsenoside
R1, lobetyolin, and lobetyolinin were selected to validate activity.
Measurement of ECG of adult zebrafish also performed as a
complement. Our results suggest that integrate bio-assay and
substantial analysis to perform active index calculation improve
the efficiency of active compounds discovering from TCM, and
this approach is possible to be applied for the research of complex
diseases.
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Protection rate of all fractions of WXKL, n= 3. (B) Dose-response of selected
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Supplementary Figure 3 | Dose effect of Terfenadine on heart rate of zebrafish.
∗∗P < 0.01 vs. control. n= 8.
Video 1 | Side view of heart of zebrafish larva in normal group.
Video 2 | Vertical view of heart of zebrafish larva in normal group.
Video 3 | Side view of heart of zebrafish larva in terfenadine group.
Video 4 | Vertical view of heart of zebrafish larva in terfenadine group.
Video 5 | Side view of heart of zebrafish larva in WXKL group.
Video 6 | Vertical view of heart of zebrafish larva in WXKL group.
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